fda warns against semaglutide of Overdoses With Compounded FDA warns against compounded versions

Retatrutide is a multi-receptor agonist peptide currently in research for significant weight loss and metabolic improvement

If you reach 6-8 weeks on an adequate dose with proper technique and see minimal results, the conversation with your provider should include discussing whether sublingual delivery is providing sufficient bioavailability for your needs, or whether transitioning to injectable administration might be more effective

Add the water slowly down the inside wall of the vial and swirl gently, do not shake

This reflects the average results seen in clinical trials once patients had reached the highest doses of each medication

Evidence is mixed but potentially helpful and safe

McCormack, P